The contract research organization consolidation trend continues with Worldwide Clinical Trials striking a deal for Catalyst Clinical Research, which has particular expertise in oncology. Worldwide is a portfolio company of Kohlberg, a private equity firm.
The post Worldwide Clinical Trials to Buy Catalyst, Another M&A Deal Between Private Equity-Backed CROs appeared first on MedCity News.
